4-乙基-1-甲基-4-苯基-哌啶 | 101775-16-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 中文名称: 4-乙基-1-甲基-4-苯基-哌啶
• 英文名称: 4-ethyl-1-methyl-4-phenyl-piperidine
• 英文别名: 4-Aethyl-1-methyl-4-phenyl-piperidin；4-Ethyl-1-methyl-4-phenylpiperidine
• CAS: 101775-16-0
• 化学式: C₁₄H₂₁N
• 分子量: 203.327
• InChiKey: FTKBJBCJGZZYMG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  3.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  9-ethyl-9-phenyl-3,7-diaza-bicyclo[3.3.1]nonane-2,4,6,8-tetraone 在 1,4-二氧六环 、 甲酸 、 copper oxide-chromium oxide 作用下， 250.0 ℃ 、24.51 MPa 条件下， 生成 4-乙基-1-甲基-4-苯基-哌啶
  参考文献：
  名称：

  Piperidine Derivatives. XXX. 1,4-Dialkyl-4-arylpiperidines

  摘要：

  DOI：

  10.1021/ja01548a030

文献信息

• PYRROLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
  申请人：Barth Francis

  公开号：US20070149596A1

  公开（公告）日：2007-06-28

  The invention concerns compounds of formula (I): Wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are as defined herein. The invention also concerns the method for preparing said compounds and their therapeutic use.

  该发明涉及式(I)的化合物：其中R1、R2、R3、R4、R5、R6、R7、R8和R9如本文所定义。该发明还涉及制备所述化合物的方法及其治疗用途。
• NOVEL ANTIVIRAL AGENTS AGAINST HBV INFECTION
  申请人：DREXEL UNIVERSITY

  公开号：US20160024004A1

  公开（公告）日：2016-01-28

  The present invention provides novel compounds of formula (I) and methods of use thereof. In certain embodiments, the compounds of the invention are useful as nucleocapsid assembly inhibitors. In other embodiments, the compounds of the invention are useful as pregenomic RNA encapsidation inhibitors of Hepatitis B virus (HBV). In yet other embodiments, the compounds of the invention are useful for the treatment of viral infection, including HBV and related viral infections.

  本发明提供了式(I)的新化合物及其使用方法。在某些实施例中，本发明的化合物可用作核衣壳组装抑制剂。在其他实施例中，本发明的化合物可用作乙型肝炎病毒（HBV）的前基因组RNA包装抑制剂。在其他实施例中，本发明的化合物可用于治疗病毒感染，包括HBV和相关病毒感染。
• CETP INHIBITORS DERIVED FROM BENZOXAZOLE ARYLAMIDES
  申请人：HUNT Julianne A.

  公开号：US20100298288A1

  公开（公告）日：2010-11-25

  Compounds having the structure of Formula I1 including pharmaceutically acceptable salts of the compounds, are potent CETP (cholesterol ester transfer protein) inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis Atherosclerosis and its clinical consequences, coronary heart disease (CHD), stroke and penpheral vascular disease, represent a truly enormous burden to the health care systems of the industrialized world In formula I, A-B is an arylamide moiety

  具有I1式结构的化合物，包括化合物的药学上可接受的盐，是有效的CETP（胆固醇酯转移蛋白）抑制剂，可用于升高HDL-胆固醇，降低LDL-胆固醇，并用于治疗或预防动脉粥样硬化及其临床后果，如冠心病（CHD）、中风和周围血管疾病，对工业化国家的医疗保健系统构成巨大负担。在式I中，A-B是一个芳香酰胺基团。
• Quinuclidines. I. 4-Phenylquinuclidines as Potential Analgesics^*
  作者：T. D. PERRINE

  DOI：10.1021/jo01362a043

  日期：1957.11
• PYRROLE DERIVATIVES, INTERMEDIATES THEREFOR, PREPARATION AND THERAPEUTIC USE THEREOF
  申请人：BARTH Francis

  公开号：US20080194581A1

  公开（公告）日：2008-08-14

  The invention concerns compounds of formula (I): Wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 and R 9 are as defined herein. The invention also concerns the method for preparing said compounds including the intermediates therefor and their therapeutic use.